Spoken Alpha
Nautilus Biotechnology, Inc.
Nautilus Biotechnology develops the Nautilus Voyager platform, a proteomics instrument designed to measure and quantify proteins and their functional variants (proteoforms) in biological samples with broad coverage, single-molecule depth, and high reproducibility.
Nautilus Biotechnology, Inc is a Healthcare company operating in Biotechnology with a $129.8M market cap.
Most recent reported earnings: Q3 FY2026 (Oct 25, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NAUT.
$ curl https://api.spokenalpha.com/v1/companies/NAUTFAQ
Spoken Alpha indexes NAUT's earnings call transcripts at https://spokenalpha.com/companies/NAUT. Each call links to attributed speakers and parsed analyst Q&A.
Nautilus Biotechnology, Inc. (NAUT) held its most recent earnings call on 2026-07-28, covering fiscal Q2 2026.
Nautilus Biotechnology, Inc. (NAUT) operates in the Healthcare sector (Biotechnology industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-25 | — | — | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-07-27 | $-0.11 | $-0.14 | +21.4% | $190.0K | — | — | EODHD |
| Q1 FY2026 | 2026-04-27 | $-0.12 | $-0.14 | +14.3% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-02-25 | $-0.11 | $-0.15 | +29.0% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-10-27 | $-0.11 | $-0.15 | +26.7% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-07-30 | $-0.12 | $-0.14 | +14.3% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-04-28 | $-0.13 | $-0.14 | +7.1% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-02-26 | $-0.14 | $-0.15 | +6.7% | $9.6M | — | — | EODHD |
| Q3 FY2024 | 2024-10-28 | $-0.13 | $-0.17 | +23.5% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-07-29 | $-0.14 | $-0.16 | +12.5% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-04-29 | $-0.15 | $-0.16 | +6.3% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-02-27 | $-0.14 | $-0.14 | 0.0% | $8.2M | — | — | EODHD |
| Q3 FY2023 | 2023-10-30 | $-0.13 | $-0.16 | +18.8% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-01 | $-0.13 | $-0.16 | +18.8% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-01 | $-0.12 | $-0.17 | +29.4% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-02-22 | $-0.11 | $-0.15 | +26.7% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-10-31 | $-0.11 | $-0.15 | +26.7% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-01 | $-0.12 | $-0.17 | +29.4% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-02 | $-0.13 | $-0.16 | +18.8% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $-0.13 | $-0.13 | 0.0% | $0 | — | — | EODHD |
Source: EODHD. NAUT reported actuals as published; sparse fields render as —.